Ketamine, esketamine, and ECT can rapidly ease suicidal thoughts, but evidence for preventing attempts or deaths remains limited—see what’s proven.
Poll|Articles|January 11, 2024
Have You Seen Increased Suicidal Ideation in Your Patients?
Author(s)Psychiatric Times Editors
Listen
0:00 / 0:00
Key Takeaways
- Healthcare professionals are encouraged to share experiences of increased suicidal ideation or patient suicides to inform a cover story.
- The initiative aims to understand trends and factors contributing to mental health challenges among patients.
Take our poll!
Advertisement
In preparation for our March cover story, we will be releasing a series of polls on suicide.
Here's our first question:
Have you seen increased suicidal ideation in your patients?
If you have seen increased suicidal ideation in your patients, or if you've had a patient commit suicide, share more of your experience with us at
Advertisement
Related to this article
Learn how clozapine, lithium, ketamine, and antidepressants fit into suicide prevention, from rapid crisis relief to long-term risk reduction.
Can hormones flag suicide risk in schizophrenia? Review links cortisol, thyroid and testosterone shifts—and clozapine/lithium pathways—to risk.
How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Clinicians Need to Know About Postpartum Psychosis
2
Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD
3
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
4
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
5